Anaesthesia for implantation of the Jarvik 2000 Flowmarker® LVAD

Anaesthesia and Intensive Care

Volumn 34, Issue 6, 2006, Pages 746-752

  Tan, L H ^a,b   Cokis, C ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

^b CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Anaesthesia; Jarvik 2000 flowmaker ; Ventricular assist device

Indexed keywords

ADRENALIN; ANTHRACYCLINE; APROTININ; DOBUTAMINE; DOPAMINE; ESMOLOL; FENTANYL; FRESH FROZEN PLASMA; GENTAMICIN; GLYCERYL TRINITRATE; LEVOSIMENDAN; LORAZEPAM; MILRINONE; MORPHINE; NITRIC OXIDE; NORADRENALIN; OPIATE; PANCURONIUM; PROTAMINE; SEVOFLURANE; VANCOMYCIN; VASOPRESSIN;

ADULT; AGED; ANEMIA; ANESTHESIA; ANESTHESIA INDUCTION; ARTICLE; BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; EPISTAXIS; GOUT; HEART ASSIST DEVICE; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE FAILURE; HEMATOTHORAX; HEMODIALYSIS; HUMAN; HYPOTENSION; IMPLANTATION; INTESTINAL BLEEDING; ISCHEMIA; MALE; MUSCULAR DYSTROPHY; OPERATION DURATION; PNEUMONIA; SINUSITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URINE VOLUME;

EID: 33845899366     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0603400605     Document Type: Article

References (14)

1. Frazier OH, Myers TJ, Gregoric ID et al. Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2002; 105:2855-2860.
2. Westaby S, Banning AP, Saito S et al. Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation 2002; 105:2588-2591.
3. Siegenthaler MP, Martin J, Van de Loo A, Doenst T, Bothe W, Beyersdorf F. Implantation of the permanent Jarvik-2000 left ventricular assist device. J Am Coll Cardiol 2002; 39:1764-1772.
4. Frazier OH. Implantatation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass. Ann Thorac Surg 2003; 75:1337-1340.
5. Nussmeier NA, Probert CB, Hirsch D et al. Anesthetic management for implantation of the Jarvik 2000™ left ventricular assist system. Anesth Analg 2003; 97:964-971.
6. Westaby S, Frazier OH, Pigott DW, Saito S, Jarvik RK. Implant technique for the Jarvik 2000 Heart. Ann Thorac Surg 2002; 73:1337-1340.
7. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 2004; 77:133-142.
8. Myers TJ, Robertson K, Pool T, Shah N, Gregoric I, Frazier OH. Continuous flow pumps and total artificial hearts: management issues. Ann Thorac Surg 2003; 75:S79-85.
9. Siegenthaler MP, Martin J, Pernice K et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothoracic Surg 2003; 23:748-755.
10. Mets B. Anesthesia for left ventricular assist device placement. J Cardiothor Vasc Anesth 2000; 14:316-326.
11. Hirsch DJ, Cooper JR. Cardiac Failure and left ventricular assist devices. Anesthesiol Clin Nth Am 2003; 21:625-638.
12. Radovancevic B, Gregoric ID, Tamez D et al. Biventricular support with the Jarvik 2000 axial flow pump: a feasibility study. ASAIO J 2003; 49:604-607.
13. Goldstein DJ, Mehmet CO, Rose EA. Implantable left ventricular assist devices. N Engl J M 1998; 339:1522-1533.
14. Goldstein D, Seldomridge J, Chen J et al. Use of aprotinin in LVAD recipients reduces blood loss, blood use and periopoerative mortality. Ann Thorac Surg 1995; 59:1063-1067.